Compare WABC & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WABC | ABCL |
|---|---|---|
| Founded | 1972 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | N/A | 2020 |
| Metric | WABC | ABCL |
|---|---|---|
| Price | $48.97 | $3.66 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $52.00 | $7.75 |
| AVG Volume (30 Days) | 112.9K | ★ 4.0M |
| Earning Date | 01-15-2026 | 11-06-2025 |
| Dividend Yield | ★ 3.77% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.59 | N/A |
| Revenue | ★ $264,660,000.00 | $35,325,000.00 |
| Revenue This Year | N/A | $25.45 |
| Revenue Next Year | N/A | $10.07 |
| P/E Ratio | $10.62 | ★ N/A |
| Revenue Growth | N/A | ★ 7.17 |
| 52 Week Low | $42.00 | $1.89 |
| 52 Week High | $57.65 | $6.52 |
| Indicator | WABC | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 55.87 | 40.58 |
| Support Level | $46.93 | $3.51 |
| Resistance Level | $49.50 | $3.84 |
| Average True Range (ATR) | 1.19 | 0.18 |
| MACD | 0.09 | 0.08 |
| Stochastic Oscillator | 63.40 | 48.86 |
Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California and all the way east to Nevada County.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.